Search Within

William Thomas Johnson

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (6)
  3. Research Letter (3)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (34)
  2. Department of Medicine (34)
  3. Hematologic Malignancies, Division of (34)
  4. Lymphoma (34)
  5. Population Sciences Research Program (34)
  6. Hematology-Oncology Fellows (29)

More Groups

People
  1. Steven Horwitz (34)
  2. Alison Moskowitz (32)
  3. Zachary Epstein-Peterson (24)
  4. Gilles Salles (23)
  5. Santosha Vardhana (23)
  6. Ariela Noy (22)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (14)
  4. 2022 (7)
  5. 2021 (4)
Publications
  1. Blood (22)
  2. Blood Advances (3)
  3. Haematologica (2)
  4. Hematological Oncology (2)
  5. Journal of Clinical Oncology (2)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Wiley Blackwell (3)
  3. American Society of Clinical Oncology (2)
  4. Ferrata Storti Foundation (2)
  5. C M P Medica LLC * The Oncology Group (1)
  6. Nature Publishing Group (1)

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk peripheral T-cell lymphoma patients treated with CHOP-based chemotherapy
    Meeting Abstract

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Maccaro, C.; Galasso, N.; Sauter, C. S.; Neuman, R.; Khan, N.; Moskowitz, A. J.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save